Skip to main content
Caplight Logo









BioEye Ltd.

BioEye Ltd.

Private
IsraelHealthcare & Life Scienceshttps://braineye.com/

Last Round

Early Funding

Apr 1, 2025

Total Funding Raised

$19.5M

Momentum

Top 5%

of companies Caplight tracks

Company Overview

BioEye Ltd. is a health technology company that develops a mobile eye-tracking platform for the continuous passive monitoring of cognitive states and early detection of cognitive decline.

Sector

Healthcare & Life Sciences

Verticals

Medical AI, Computer Vision, Healthcare Analytics, Medical Devices, Mental Health

Business Model

B2C

Customer Profile

Subscription SaaS, Services & Consulting

AI Layer

Application

Keywords

eye-tracking softwaredigital biomarkersneurological screeningcognitive monitoringmobile healthmHealthmedical diagnosticscomputer visionbrain healthdigital healthtelehealthAI diagnosticsremote patient monitoringRPMclinical research tools

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

BioEye Ltd. Comparables

Compare BioEye Ltd. with similar companies based on industry and business-model similarity.

BioEye Ltd. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Ai-BrainScience Inc.
83%
NeuroSync
78%
ViewMind Inc.
78%

BioEye Ltd. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Early FundingApr 1, 2025

Key People

Founding team and executive leadership

Nick Allan

Chief Executive Officer

Executive Team

BioEye Ltd. Investors

Notable investors and investment history

BioEye Ltd. investors
InvestorRounds
XV CapitalEarly Funding
ANDHealthEarly Funding

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 21, 2026

    Monthly visitors grew 272% MoM, reaching 3.7K.

  • Apr 18, 2026

    Monthly visitors increased 82% MoM.

BioEye Ltd. Filings

Explore SEC and related filing metadata, where available.

BioEye Ltd. filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about BioEye Ltd.'s valuation, stock price, and market status.

Is BioEye Ltd. a public or private company?

BioEye Ltd. is a private company.

What is the current stock price of BioEye Ltd.?

BioEye Ltd. is a private company with no public stock price. No recent secondary market data is available.

How much is BioEye Ltd. worth (valuation)?

Valuation information for BioEye Ltd. is not publicly available.

Can I buy BioEye Ltd. stock?

BioEye Ltd. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was BioEye Ltd.'s last funding round?

BioEye Ltd.'s most recent funding round was Early Funding on April 1, 2025.

Who are the main investors in BioEye Ltd.?

Key investors in BioEye Ltd. include XV Capital, ANDHealth.

Will BioEye Ltd. IPO soon?

No public IPO plans have been announced for BioEye Ltd..

How can I track BioEye Ltd. secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor BioEye Ltd.'s secondary market activity and sign up for updates.

Firmographic Details

HeadquartersIsrael
Employee Range26
Year Founded2014
Last FundingApr 1, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?